{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T01:06:17Z","timestamp":1716080777507},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,18]]},"DOI":"10.7759\/cureus.60557","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T16:10:32Z","timestamp":1716048632000},"source":"Crossref","is-referenced-by-count":0,"title":["When Blood Cell Counts Matter: Hypereosinophilic Syndrome as a Rare Cause of Ischemic Strokes"],"prefix":"10.7759","author":[{"given":"Gunjanpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoan","family":"Ganev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lissette","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Overberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall  C","family":"Edgell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13437","article-title":"Causes of hypereosinophilia in 100 consecutive patients","volume":"105","author":"Moller D","year":"2020","unstructured":"Moller D, Tan J, Gauiran DT, et al.. Causes of hypereosinophilia in 100 consecutive patients. Eur J Haematol. 2020, 105:292-301. 10.1111\/ejh.13437","journal-title":"Eur J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2008.09.010","article-title":"Hypereosinophilic syndromes","volume":"22","author":"Kahn JE","year":"2008","unstructured":"Kahn JE, Bl\u00e9try O, Guillevin L. Hypereosinophilic syndromes. Best Pract Res Clin Rheumatol. 2008, 22:863-82. 10.1016\/j.berh.2008.09.010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-37","article-title":"Hypereosinophilic syndromes","volume":"2","author":"Roufosse FE","year":"2007","unstructured":"Roufosse FE, Goldman M, Cogan E. Hypereosinophilic syndromes. Orphanet J Rare Dis. 2007, 2:37. 10.1186\/1750-1172-2-37","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2007.07.001","article-title":"Cardiovascular manifestations of hypereosinophilic syndromes","volume":"27","author":"Ogbogu PU","year":"2007","unstructured":"Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007, 27:457-75. 10.1016\/j.iac.2007.07.001","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0787","article-title":"FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia","volume":"104","author":"Pardanani A","year":"2004","unstructured":"Pardanani A, Brockman SR, Paternoster SF, et al.. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood. 2004, 104:3038-45. 10.1182\/blood-2004-03-0787","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2007.07.007","article-title":"Clinical overview of hypereosinophilic syndromes","volume":"27","author":"Sheikh J","year":"2007","unstructured":"Sheikh J, Weller PF. Clinical overview of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007, 27:333-55. 10.1016\/j.iac.2007.07.007","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.03.035","article-title":"Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence","volume":"126","author":"Crane MM","year":"2010","unstructured":"Crane MM, Chang CM, Kobayashi MG, Weller PF. Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol. 2010, 126:179-81. 10.1016\/j.jaci.2010.03.035","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000668","article-title":"Hypereosinophilic syndrome: Hacettepe experience","volume":"38","author":"Tavil B","year":"2016","unstructured":"Tavil B, Ayta\u00e7 S, Unal S, Kuskonmaz B, Gumruk F, Cetin M. Hypereosinophilic syndrome: Hacettepe experience. J Pediatr Hematol Oncol. 2016, 38:539-43. 10.1097\/MPH.0000000000000668","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/all.14368","article-title":"Medical algorithm: diagnosis and treatment of hypereosinophilic syndrome","volume":"75","author":"Schuster B","year":"2020","unstructured":"Schuster B, Zink A, Eyerich K. Medical algorithm: diagnosis and treatment of hypereosinophilic syndrome. Allergy. 2020, 75:3003-6. 10.1111\/all.14368","journal-title":"Allergy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools J","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J, et al.. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003, 348:1201-14. 10.1056\/NEJMoa025217","journal-title":"N Engl J Med"},{"key":"ref11","article-title":"Chronic eosinophilic leukemia initially presenting with psychotic symptoms: one case report and literature review","volume":"12","author":"Muhashi M","year":"2019","unstructured":"Muhashi M, Yuan H, Qu J, Duan X, Xu J, Chen G, Jiang M. Chronic eosinophilic leukemia initially presenting with psychotic symptoms: one case report and literature review. Int J Clin Exp Med. 2019, 12:10945-9.","journal-title":"Int J Clin Exp Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307959","article-title":"Hypereosinophilic syndrome: cardiac diagnosis and management","volume":"102","author":"Mankad R","year":"2016","unstructured":"Mankad R, Bonnichsen C, Mankad S. Hypereosinophilic syndrome: cardiac diagnosis and management. Heart. 2016, 102:100-6. 10.1136\/heartjnl-2015-307959","journal-title":"Heart"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2022.05.019","article-title":"The hypereosinophilic syndrome - an unusual cause of myocarditis and cardioembolic strokes","volume":"364","author":"Ryan D","year":"2022","unstructured":"Ryan D, Inamullah O, El Husseini N, Wang E, Selim MA, Feng W. The hypereosinophilic syndrome - an unusual cause of myocarditis and cardioembolic strokes. Am J Med Sci. 2022, 364:661-8. 10.1016\/j.amjms.2022.05.019","journal-title":"Am J Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100915","article-title":"Literature reviews of stroke with hypereosinophilic syndrome","volume":"37","author":"Ono R","year":"2021","unstructured":"Ono R, Iwahana T, Kato H, Okada S, Kobayashi Y. Literature reviews of stroke with hypereosinophilic syndrome. Int J Cardiol Heart Vasc. 2021, 37:100915. 10.1016\/j.ijcha.2021.100915","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.06.004","article-title":"Distal ischemia as the initial presentation of hypereosinophilic syndrome-related arterial involvement: a case study and literature review","volume":"18","author":"Rohmer J","year":"2019","unstructured":"Rohmer J, Groh M, Samson M, et al.. Distal ischemia as the initial presentation of hypereosinophilic syndrome-related arterial involvement: a case study and literature review. Autoimmun Rev. 2019, 18:828-30. 10.1016\/j.autrev.2019.06.004","journal-title":"Autoimmun Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034191","article-title":"FIP1L1-PDGFRA-associated hypereosinophilic syndrome as a treatable cause of watershed infarction","volume":"18","author":"Tennenbaum J","year":"2019","unstructured":"Tennenbaum J, Groh M, Venditti L, et al.. FIP1L1-PDGFRA-associated hypereosinophilic syndrome as a treatable cause of watershed infarction. Autoimmun Rev. 2019, 18:828-30. 10.1161\/STROKEAHA.121.034191","journal-title":"Autoimmun Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01941-8","article-title":"Acute progressive stroke with middle cerebral artery occlusion caused by idiopathic hypereosinophilic syndrome: a case report","volume":"20","author":"Li QF","year":"2020","unstructured":"Li QF, Zhang Q, Huang YF, Zhang ZX. Acute progressive stroke with middle cerebral artery occlusion caused by idiopathic hypereosinophilic syndrome: a case report. BMC Neurol. 2020, 20:361. 10.1186\/s12883-020-01941-8","journal-title":"BMC Neurol"},{"key":"ref18","article-title":"Hypereosinophilic syndrome with recurrent strokes: a case report","volume":"17","author":"Chang WL","year":"2008","unstructured":"Chang WL, Lin HJ, Cheng HH. Hypereosinophilic syndrome with recurrent strokes: a case report. Acta Neurol Taiwan. 2008, 17:184-8.","journal-title":"Acta Neurol Taiwan"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.12.002","article-title":"Embolism and impaired washout: a possible explanation of border zone strokes in hypereosinophilic syndrome","volume":"325","author":"Aida L","year":"2013","unstructured":"Aida L, Parkhutik V, Tembl JI, Mart\u00edn N, Frasquet M, Bataller L. Embolism and impaired washout: a possible explanation of border zone strokes in hypereosinophilic syndrome. J Neurol Sci. 2013, 325:162-4. 10.1016\/j.jns.2012.12.002","journal-title":"J Neurol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244386-when-blood-cell-counts-matter-hypereosinophilic-syndrome-as-a-rare-cause-of-ischemic-strokes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T16:10:37Z","timestamp":1716048637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244386-when-blood-cell-counts-matter-hypereosinophilic-syndrome-as-a-rare-cause-of-ischemic-strokes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.60557","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,18]]}}}